Lewis Williams, Director at Five Prime Therapeutics, holds 455.34K shares in Five Prime Therapeutics (Ticker: FPRX), holds ― shares in Protagonist Therapeutics (Ticker: PTGX), holds ― shares in Neurogene (Ticker: NGNE).
What is the percentage of profitable transactions made by Lewis Williams?
The percentage of profitable transactions made by Lewis Williams is 0%.
What is the average return per transaction made by Lewis Williams?
The average return per transaction made by Lewis Williams is -40.80%.
What stocks does Lewis Williams hold?
Lewis Williams holds: FPRX, PTGX, NGNE, ACLX stocks.
What was Lewis Williams’s latest transaction?
Lewis Williams latest transaction was an Uninformative Sell of $38.14K.
What was Lewis Williams's most profitable transaction?
Lewis Williams’s most profitable transaction was an Informative Buy of FPRX stock on May 13, 2016. The return on the trade was -26.80%.
What is Lewis Williams's role in Five Prime Therapeutics?
Lewis Williams's role in Five Prime Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.